A Discussion Between Thoracic Radiologist John Newell, MD, and VIDA CEO Susan Wood, PhD On May 1, 2020, during AuntMinnie's 2020 Virtual Conference, Dr. Newell and Dr. Wood discussed the evolving role of imaging for COVID-19 and the importance of a holistic, quantitative approach to managing patients with respiratory conditions.
VIDA provides personalized care solutions that can help pulmonologists identify specific disease phenotypes as well as decide on the most appropriate treatments Note: The following press release was issued by Frost and Sullivan on April 1, 2020 and is republished here in full. SANTA CLARA, Calif., April 1, 2020 /CNW/ -- Based
Coralville, IA (October 14, 2019) — VIDA Diagnostics, Inc. (“VIDA”), the leader in AI-powered lung imaging analysis, announced a distribution agreement with TeraRecon, Inc., a leader in advanced visualization, artificial intelligence, image viewing, and post-processing. With this agreement, VIDA’s LungPrint® analysis will be available through TeraRecon’s AI Interoperability platform, EnvoyAI, expanding
Our CEO, Susan Wood, was recently interviewed by the Nuance team about LungPrint and the AI market in general. See the full interview on the What's Next Blog by Nuance. Click Here to Read More -end-
